FDA Approved: TENORETIC — Supplemental Application (Upsher-Smith Laboratories, LLC)

View source ↗

Summary

The FDA approved a supplemental application for Tenoretic, a fixed-dose combination of atenolol and chlorthalidone from Upsher-Smith Laboratories.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• TENORETIC (ATENOLOL AND CHLORTHALIDONE)

Snippet

SUPPL AP for TENORETIC (ATENOLOL AND CHLORTHALIDONE)